冠心病左主干和(或)三支病变介入治疗与冠脉旁路移植的比较研究进展

The advances of interventional therapy and coronary artery bypass grafting for left main and/or triple vessel disease of coronary artery disease

长期以来,冠状动脉旁路移植术(CABG)是冠心病左主干和(或)三支病变患者的首选血运重建治疗方案。近年来,随着腔内影像学技术的快速发展和新型支架的研发和应用,经皮冠状动脉介入治疗(PCI)术后远期通畅率有一定的提高,靶血管再血管化率有所降低,成为冠心病左主干和三支病变的可供选择的治疗方法之一。本文总结冠心病左主干和(或)三支病变血运重建方式的最新研究进展,为临床决策提供依据。

Coronary artery bypass grafting(CABG)has been the preferred choice of treatment for left main coronary artery disease(LMCAD)and triple vessel disease(TVD)for quite long time.In recent years,due to the rapid development of endoluminal imaging technology and the introduction of novel coronary artery stents,percutaneous coronary intervention(PCI)has become one of the alternative treatment choice for LMCAD and TVD as the long-term patency and target vessel revascularisation rates have been improved compared with the previous ones.But there is still no international consensus on therapeutic decision-making for LMCAD and TVD lesions.This paper summarizes the available evidence on the long-term outcomes of these two therapeutic strategies for LMCAD and TVD lesions in order to aid clinical decision-making and improve the therapeutic effect.